The FDA announced on July 10, 2025, that Biofire Defense is recalling FilmArray NGDS Warrior Panel (NGDS-ASY-0007) due to an increased risk of internal control failures when testing positive blood culture. This defect may lead to delayed results and additional diagnostic workup.
How to tell if you have it
- Brand: Biofire Defense
- Product: FilmArray NGDS Warrior Panel
- Model/Lot: NGDS-ASY-0007
- Lot Codes/Expiration: 324324D(2026-02-19), D241022(2026-01-22), 319524D(2025-11-20), 315424D(2025-10-09), 315224D(2025-10-03), 315324D(2025-10-08)
- UDI-DI: 00851458005136
- Quantity: 130 Kits
- Distribution: US Nationwide in AL, AZ, UT, CA, TX, DC, VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA
The hazard
The FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture. This issue may lead to delayed results and additional diagnostic workup.
Context
GovInfoNow's records show Biofire Defense has two other recalls on record since August 20, 2019. On July 16, 2026, the firm recalled a FilmArray NGDS Warrior Panel due to an outbreak strain mismatch risk. On August 20, 2019, Biofire Defense recalled a FilmArray NGDS Warrior Panel for including an incorrect instruction for use revision. Other recent recalls of similar products include BioFire Joint Infection Panel Recall (April 22, 2026), BioFire Spotfire Respiratory Panel Recall (April 1, 2026), and BioFire Respiratory Panel 2.1 Recall (October 22, 2025).